Response Genetics, Inc. Reports First Quarter 2010 Financial Results

May 14, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LOS ANGELES--(BUSINESS WIRE)--Response Genetics Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated financial results for the three months ended March 31, 2010.

Twitter
LinkedIn
Facebook
Email
Print

Earnings